Exabis Library
Welcome to the e-CCO Library!
P476: Fermentable carbohydrates (FODMAPs) as triggers of functional gastrointestinal symptoms in patients with quiescent inflammatory bowel disease: a double-blind, placebo-controlled, randomised, cross-over re-challenge trial
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P476: Sigmoidostomy or Hartman's procedure during laparoscopic subtotal colectomy for acute colitis complicating inflammatory bowel disease? A comparative study in 129 consecutive patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P476: Using small bowel and colon video capsule endoscopy to optimise Crohn’s disease therapy may improve patient quality of life
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P477 Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P477: Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P477: Clinical remission by legacy vs. FDA definitions: definition justification and results from UNIFI Study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P477: Effect of tumour necrosis factor antagonists on avoiding surgery in stricturing Crohn’s disease: a tertiary centre real-life experience
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P477: Patient satisfaction and cost saving analysis of telemedicine in patients with inflammatory bowel disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P477: Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE Open
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P477: The efficacy of adalimumab for the treatment of Korean patients with ulcerative colitis and predictors of response: Preliminary results
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P478 Thiopurines’ metabolites levels and drug toxicity: a systematic review and meta-analysis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P478: Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous maintenance therapy: an observational multicentre study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P478: How often high-dose budesonide is necessary for maintenance treatment of collagenous colitis? Efficacy of azathioprine to maintain budesonide-free clinical remission
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P478: Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P478: Platelet-related indicators for predicting vedolizumab response in patients with Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P478: The current place of probiotics in treatment of pouchitis: systematic review
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P478: The role of proactive measurement of adalimumab trough levels and antibodies to adalimumab in Greek patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P478: Treatment with ferric maltol associated with improvements in quality of life for IBD patients with iron deficiency anaemia
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P479 The effect of adalimumab on linear growth in children with Crohn’s disease: a post hoc analysis of the PAILOT randomised control trial
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P479: Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM